The telmisartan renoprotective study from incipient nephropathy to overt nephropathy - Rationale, study design, treatment plan and baseline characteristics of the incipient to overt: Angiotensin II receptor blocker, telmisartan, investigation on type 2 diabetic nephropathy (INNOVATION) study

H. Makino, M. Haneda, T. Babazono, T. Moriya, S. Ito, Y. Iwamoto, R. Kawamori, M. Takeuchi, S. Katayama

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The telmisartan renoprotective study from incipient nephropathy to overt nephropathy - Rationale, study design, treatment plan and baseline characteristics of the incipient to overt: Angiotensin II receptor blocker, telmisartan, investigation on type 2 diabetic nephropathy (INNOVATION) study'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences